Neurology Online Review 2017  VIDEO+ PDF

Faculty and Topics

• Agnieska Ardelt, MD, Ph.D., MBA Associate Professor of Neurology and Surgery University of Chicago 
  
  Intracranial Hypertension, Brain and Spinal Cord Trauma, Encephalopathy and Coma, Acute Ischemic Stroke, Intracranial Hemorrhage

• Erik Ensrud, MD Assistant Professor of Neurology Oregon Health Sciences University
  
  Focal Neuropathies, Spine and Spinal Cord, MS and Demyelinating Diseases, Neuromuscular Junction, Anterior Horn Cell, Peripheral Neuropathies, Myopathies

• Thomas Geller, MD Professor of Child Neurology St. Louis University
  
  Neurology In The Nursery I and II, Neurologic Disorders of Infancy I and II,  Neuro-Oncology and Paraneoplastic Disorders

• Molly Gilbert, MD Clinical Assistant Professor of Ophthalmology James A. Lovell FHCC, Chicago, Illinois
  
  Neuro-Ophthalmology I and II

• Douglas Gould, Ph.D. Professor of Neuroscience Oakland University 
  
  Neuroanatomy I Peripheral Nerve, Neuroanatomy II Central Nervous System, Neuroanatomy III Motor, Neuroanatomy IV Sensory, Neuroanatomy V Visual System, Neuroanatomy VI Auditory, Neuroanatomy VII Diencephalon And Limbic Systems

• Ajay Gupta, MD Associate Professor of Neurology Cleveland Clinic Foundation
  
  Epilepsy, Sleep and EEG I and II, Epilepsy, Sleep and EEG III and IV, Neurochemistry and Neurotransmitters, Neurocutaneous Disorders, Neurogenetics

• Charles Marcuccilli, MD, Ph.D. Associate Professor of Pediatrics University of Chicago 
  
  Infections Developmental Disorders, Neurodegenerative Metabolic Disorders, Vertigo and Hearing Loss or Neuro-otology

• Muhammad Nashatizadeh, MD† Clinical Assistant Professor of Neurology University of Kansas 
  
  Movement Disorders I (Parkinsonism), Movement Disorders II (Tremor / Myoclonus), Movement Disorders III (Hyperkinetic), Stroke Syndromes, Stoke Prevention (Stoke Risk Reduction), Toxic and Environmental Neurology, Neurocritical Care, Neuroimaging I Diffusion and Perfusion, Neuroimaging II Epilepsy, Neuroimaging III Cranial Nerves, Neuroimaging IV Demyelinating Diseases, Neuroimaging V Spine, Autonomic Disorders

• Kathy Newell, MD Associate Prof and Director of Neuropathology University of Kansas 
  
  Neuropathology I – III

• Michael Newton, MD Associate Clinical Prof Emeritus of Psychiatry University of Cincinnati 
  
  Psychopharmacology I and II, Psychotherapy and PSY Miscellaneous Topics, Substance Abuse

• Simon Ovanessian, MD Chairman, RWJ Barnabas Hospital, Toms River, New Jersey
  
  Headache Syndromes and Other Pain Disorders, Psychiatric Disorders, Dementia and Ataxia, Aphasia, Apraxia, and Agnosia, 

†Course Program Planning Committee

Faculty, Planner, and Reviewer Disclosure Declaration

In compliance with the Standards, Guidelines, and Ethical opinions of the ACCME, AAMC and AMA, The Osler Institute requires that anyone with input into the planning or presentation of Continuing Medical Education activities provided or jointly-provided by The Osler Institute must disclose to the program audience any relevant financial relationships with companies or organizations about whose products or services they are discussing in their presentations. Copies of the Faculty Disclosure Forms will be available during this program.

• The following faculty/planners/reviewers disclosed a relevant financial relationship(s).

  • Ajay Gupta, MD – consultant for Malincrodt and Sunovion Pharmaceuticals as well as Elsai, Inc.

  • Simon Ovanessian, MD – speaker for Otsuka Pharmaceutical and Alkermes Co

• The following faculty/planners/reviewers listed no relevant financial relationship(s) to disclose.
  • Agnieszka Ardelt, MD, PhD, MBA
  • Erik Ensrud, MD
  • Thomas Geller, MD
  • Molly Gilbert, MD
  • Douglas Gould, MD
  • Charles Marcuccilli, MD, PhD
  • Kathy Newell, MD
  • Michael Newton, MD
  • Muhammad Nashatizadeh, MD†*
  • Angie Kowitz†
  • Joseph Selliken, MD†
  • Michael Stewart†
  • Sally Schuette, PhD†
  • Copies of the Faculty Disclosure Forms are available upon request.
    
    † Program Planning Committee
    
    * Reviewer if Applicable

Learning Objectives

At the conclusion of this course each participant will be able to:

• Identify and discuss clinically relevant aspects of neurochemistry, neuroanatomy, neurophysiology, and neuropharmacology
• Interpret neuroimaging studies
• Recognize and describe all major neurological disorders and important variants
• Discuss developmental disorders and scientific underpinnings
• Distinguish abnormal behavioral and personality changes
• Describe use of appropriate psychopharmacology agents for all major neurologic disorders and important interactions
• Identify and plan treatment for alcoholism and substance abuse
• Identify and distinguish between altered states of consciousness and memory disorders
• Implement appropriate primary and secondary stroke prevention strategies